Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

ls and communications pathways in cancer, we are improving our ability to effectively treat the disease while avoiding the toxicities of chemotherapy and potential relapse," said John C. Byrd, MD, lead author and Director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute in Columbus. "If we can replicate these high survival rates and good tolerability with ibrutinib through larger scale Phase III studies, we may find it to be an extremely valuable new therapy for not just elderly, but for all CLL patients."

Dr. Byrd will present this study in an oral presentation on Sunday, December 9, at 5:00 p.m. EST at the Georgia World Congress Center in Thomas Murphy Ballroom 4, Level 5, Building B.

The BTK Inhibitor Ibrutinib (PCI-32765) in Combination with Rituximab is Well−Tolerated and Displays Profound Activity in High-Risk Chronic Lymphocytic Leukemia (CLL) Patients [Abstract 187]

The combination of the novel investigational agent ibrutinib with an established therapeutic antibody, rituximab, may present a safer and more effective option than the current standard chemotherapy-based treatment regimen for patients with high-risk CLL.

While current chemotherapy-based treatment options for CLL patients are effective, they come with toxic side effects that are challenging for elderly patients. Physicians have long awaited new options that offer better tolerability. Ibrutinib is designed to selectively target leukemia cell growth, with the aim of effectively treating the disease without the toxicities of chemotherapy. Data from earlier studies of ibrutinib have shown it to be equally effective in both low- and high-risk CLL.

High-risk CLL patients typically have unfavorable responses to standard CLL therapies and a dismal outcome. S
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
(Date:7/1/2015)... ... 01, 2015 , ... SuiteRx, innovative leaders in pharmacy performance ... operations, announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. D., ... the Venetian Las Vegas, Nevada. During this event, SuiteRx will be highlighting ...
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy eating plan ... and eggs. Eating organic foods and products can help limit the exposure to ... than production chicken farming. Choosing home raised chickens and eggs that do not ...
(Date:7/1/2015)... ... ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, VA ... discuss non-invasive CoolSculpting . On the show, Dr. Challa will explain how CoolSculpting ... utilizes Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the slim, ...
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon ... the 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, the ... take participants from the basic training and fundamentals of nasal surgery through the most ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... to $2.3 million fine, CARMEL, Ind., May ... announced a settlement among state insurance regulators and ... (CSHI) Company,and Bankers Life and Casualty Company. The ... Pennsylvania, Illinois,Indiana, Texas and Florida related to long-term ...
... - CEO John Cassin Brings 30 Years of Business Experience To Vail ... ... The Board of Directors of the Vail,Valley Medical Center announced today ... more than 30 years of healthcare,leadership experience to the Vail Valley Medical ...
... speak a second or third language may have an ... University study has found. Knowing and speaking many languages ... , Dr. Gitit Kav, a clinical neuro-psychologist from the ... with her colleagues Nitza Eyal, Aviva Shorek, and Jiska ...
... WASHINGTON, May 7 Following the impact of,Cyclone Nargis ... and,displaced around a million more, Amnesty International is calling ... workers and ensure aid is,provided on the basis of ... visas is costing lives, while some,donors are delaying aid ...
... NHS Choices ( http://www.nhs.uk ), the new,digital ,front ... Well bundle aimed to,help people stay healthy during ... information, the Live Well Travel health guide,( http://www.nhs.uk/livewell/travelhealth/Pages/Travelhealthhome.aspx ... and provides them,with clinically approved guidance to help ...
... May 7 GlaxoSmithKline (GSK) Consumer,Healthcare, marketer of ... CQ(R) patch, and Commit(R) lozenge, applauds,the release of ... Guideline,on Treating Tobacco Use and Dependence. Too many ... cold turkey approaches to become,tobacco-free. The Guideline is ...
Cached Medicine News:Health News:Conseco Reaches Settlement of Multistate Market Conduct Examination 2Health News:Vail Valley Medical Center Board of Directors Announces Appointment of New President & CEO, John Cassin 2Health News:Tel Aviv University finds connection between mental fitness and multi-lingualism 2Health News:Myanmar Government Must Cooperate With International Community to Ensure Appropriate Aid for Victims, Urges Amnesty International 2Health News:A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence 2Health News:A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence 3
(Date:7/1/2015)... July 1, 2015   Cochlear Limited ... solutions, announced today the US Food and Drug ... Implant with Slim Straight Electrode (CI522). Built on ... close collaboration with the world,s leading surgeons, the ... designed to provide the most discreet appearance for ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 /PRNewswire/ ... study startup solutions, announced today unprecedented growth in ... "There is intense pressure to speed clinical trials ... protocols, globalization, and paper-based methods have stalled these ... "The current status of clinical trials has encouraged ...
(Date:7/1/2015)... 2015 Prismic Pharmaceuticals, Inc., a specialty pharmaceutical ... today announced the election of Joseph J. Krivulka ... Board of Directors. Commenting on the election ... , Chairman and CEO of Prismic, stated, "We are ... Simonetti have accepted our invitation to join Prismic,s ...
Breaking Medicine Technology:Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2
... 18 According to a report issued,today, drug safety ... increase resources, either internally or through,partnerships, to comply with ... Drug Administration (FDA) and European Medicines Agency (EMEA).,The report ... Clinical,Development - is based on a survey of 140 ...
... AMSTERDAM, The Netherlands, June 18 Amsterdam,Molecular ... of human gene,therapy, announced today new data showing ... results in significant long-term health benefits.,Long-term follow-up data ... GlyberaTM brings significant and clinically important,reduction in acute ...
Cached Medicine Technology:New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 2New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 3Glybera(TM) Shows Long-Term Health Benefits 2Glybera(TM) Shows Long-Term Health Benefits 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: